{"id":"W2977743112","doi":"10.1016/j.euo.2019.09.002","title":"First-line Treatment of Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis","year":2019,"lang":"en","type":"review","venue":"European Urology Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Axitinib; Medicine; Oncology; Internal medicine; Renal cell carcinoma; Population; Clinical endpoint; Pembrolizumab; Adverse effect; Progression-free survival; Clinical trial; Meta-analysis; Atezolizumab; Avelumab; Cancer; Overall survival; Immunotherapy; Sunitinib","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003401533,0.001497179,0.01001115,0.003001462,0.0003940999,0.001597331,0.00150161,0.001536707,0.004401811],"category_scores_gemma":[0.009747333,0.0009136666,0.02090614,0.004751494,0.0004727485,0.001281951,0.001145679,0.001839733,0.0003333754],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001719281,"about_ca_system_score_gemma":0.001864441,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.009371832,"about_ca_topic_score_gemma":0.03126871,"domain_scores_codex":[0.9968972,0.001188247,0.0008777744,0.0005178973,0.0003704148,0.0001484303],"domain_scores_gemma":[0.9951802,0.00313628,0.001084083,0.0001683899,0.0003214619,0.0001095356],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.002337536,0.00004561465,0.008208187,0.4121169,0.5561857,0.0001179985,0.00009039776,0.0006270891,0.0002916142,0.0001553682,0.001564474,0.01825905],"study_design_scores_gemma":[0.001016222,0.0002427197,0.008953397,0.02655651,0.9589261,0.0001360488,0.00006401942,0.0001700404,0.000104005,0.0002201361,0.003573481,0.00003722646],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.003274966,0.9955935,0.0002067163,0.00009299555,0.0000972638,0.00004704868,0.0004866658,0.00001166344,0.0001891513],"genre_scores_gemma":[0.1615224,0.8346469,0.001153965,0.001113039,0.000177807,0.0001921634,0.0008169198,0.00002434707,0.0003525424],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01001115,"threshold_uncertainty_score":0.01863456,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1707180087076591,"score_gpt":0.3583626597912709,"score_spread":0.1876446510836118,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}